Cargando…
Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246599/ https://www.ncbi.nlm.nih.gov/pubmed/25107986 http://dx.doi.org/10.14814/phy2.12093 |
_version_ | 1782346547892060160 |
---|---|
author | Al‐Alawi, Mazen Buchanan, Paul Verriere, Valia Higgins, Gerard McCabe, Olive Costello, Richard W. McNally, Paul Urbach, Valérie Harvey, Brian J. |
author_facet | Al‐Alawi, Mazen Buchanan, Paul Verriere, Valia Higgins, Gerard McCabe, Olive Costello, Richard W. McNally, Paul Urbach, Valérie Harvey, Brian J. |
author_sort | Al‐Alawi, Mazen |
collection | PubMed |
description | In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics and ion transport were studied using live‐cell confocal microscopy and short‐circuit current measurements in CF (CuFi‐1) and non‐CF (NuLi‐1) cell cultures. Low physiological concentrations of LXA4 in the picomolar range produced an increase in ASLh which was dependent on inhibition of an amiloride‐sensitive Na(+) current and stimulation of a bumetanide‐sensitive Cl(−) current. These ion transport and ASLh responses to LXA(4) were blocked by Boc‐2 an inhibitor of the specific LXA4 receptor ALX/FPR2. LXA(4) affected the subcellular localization of its receptor and enhanced the localization of ALX/FPR2 at the apical membrane of CF cells. Our results provide evidence for a novel effect of low physiological concentrations of LXA(4) to inhibit airway epithelial Na(+) absorption that results in an ASL height increase in CF airway epithelia. |
format | Online Article Text |
id | pubmed-4246599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42465992014-12-18 Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium Al‐Alawi, Mazen Buchanan, Paul Verriere, Valia Higgins, Gerard McCabe, Olive Costello, Richard W. McNally, Paul Urbach, Valérie Harvey, Brian J. Physiol Rep Original Research In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics and ion transport were studied using live‐cell confocal microscopy and short‐circuit current measurements in CF (CuFi‐1) and non‐CF (NuLi‐1) cell cultures. Low physiological concentrations of LXA4 in the picomolar range produced an increase in ASLh which was dependent on inhibition of an amiloride‐sensitive Na(+) current and stimulation of a bumetanide‐sensitive Cl(−) current. These ion transport and ASLh responses to LXA(4) were blocked by Boc‐2 an inhibitor of the specific LXA4 receptor ALX/FPR2. LXA(4) affected the subcellular localization of its receptor and enhanced the localization of ALX/FPR2 at the apical membrane of CF cells. Our results provide evidence for a novel effect of low physiological concentrations of LXA(4) to inhibit airway epithelial Na(+) absorption that results in an ASL height increase in CF airway epithelia. Wiley Periodicals, Inc. 2014-08-08 /pmc/articles/PMC4246599/ /pubmed/25107986 http://dx.doi.org/10.14814/phy2.12093 Text en © 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Al‐Alawi, Mazen Buchanan, Paul Verriere, Valia Higgins, Gerard McCabe, Olive Costello, Richard W. McNally, Paul Urbach, Valérie Harvey, Brian J. Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title | Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title_full | Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title_fullStr | Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title_full_unstemmed | Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title_short | Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
title_sort | physiological levels of lipoxin a(4) inhibit enac and restore airway surface liquid height in cystic fibrosis bronchial epithelium |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246599/ https://www.ncbi.nlm.nih.gov/pubmed/25107986 http://dx.doi.org/10.14814/phy2.12093 |
work_keys_str_mv | AT alalawimazen physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT buchananpaul physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT verrierevalia physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT higginsgerard physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT mccabeolive physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT costellorichardw physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT mcnallypaul physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT urbachvalerie physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium AT harveybrianj physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium |